ArticleCardiovascular diabetology2026
Association between atherosclerotic index of plasma and long-term aortic-related adverse events in type B aortic dissection patients undergoing thoracic endovascular aortic repair.
Article in Cardiovascular diabetology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundPrevious research identifies the atherosclerotic index of plasma (AIP) as a key marker for cardiovascular risk, but its role in predicting outcomes in type B aortic dissection (TBAD) patients after thoracic endovascular aortic repair (TEVAR) is uncertain. This study aimed to investigate the association between AIP and long-term outcomes in TBAD patients after TEVAR.
methodsThis retrospective cohort study included 1335 patients with TBAD who underwent TEVAR. Patients were stratified into tertiles based on AIP levels. The primary endpoints were aortic-related adverse events (ARAEs) at 1 and 5 years after TEVAR. Cox regression analyses were used to evaluate the independent effect of AIP on outcomes. Kaplan-Meier (KM) analysis was conducted to compare the incidence of ARAEs among different groups. Restricted cubic spline (RCS) models were utilized to investigate the nonlinear relationship between AIP and ARAEs, and subgroup analyses assessed the stability of this association. Time-dependent receiver operating characteristic (ROC) curves were applied to assess the predictive accuracy of AIP for ARAEs over a 5-year period.
resultsThe KM analysis revealed a significantly higher incidence of ARAEs in the high AIP group compared to the low AIP group (P < 0.001). However, no statistically significant differences were found in all-cause mortality and major adverse cardiovascular and cerebrovascular events (MACCEs) (all P > 0.05). Cox regression analysis demonstrated that a high level of AIP was associated with an increased risk of ARAEs (all P < 0.001). Additionally, RCS analysis indicated a linear relationship between AIP and the risk of ARAEs. In subgroup analyses, the timing of operation showed a significant interaction with 1-year ARAEs (P for interaction = 0.008). Time-dependent ROC analysis demonstrated an area under the curve approaching 0.8 throughout the 5-year period.
conclusionOur research indicates that AIP is independently associated with 1-year and 5-year ARAEs in patients with TBAD following TEVAR, providing a novel metabolic perspective for the prognostic evaluation of this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.